Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MK-4827 receives E.U. orphan drug status in ovarian cancer

Aug. 16, 2010

Italian researchers discover new SMO receptor antagonists for cancer

Aug. 16, 2010

European Commission grants orphan status to bosutinib in CML

Aug. 13, 2010

Astex and Multiple Myeloma Research Consortium start phase II AT-7519 trial

Aug. 13, 2010

Phase III panitumumab trial in head and neck cancer does not meet primary endpoint

Aug. 13, 2010

University of Ulsan identifies new anticancer prodrugs

Aug. 13, 2010

Biotest updates development program for BT-062 in multiple myeloma

Aug. 12, 2010

ACT and Brown Cancer Center collaborate to identify cancer therapeutics

Aug. 12, 2010

Herceptin approved in Canada for HER2-positive stomach cancer

Aug. 12, 2010

Algeta begins phase I/IIa trial of Alpharadin/docetaxel combination in CRPC

Aug. 12, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...